EUVIMEDEUVIMED entdecken
Crossref

Design, Synthesis, and Activity Evaluation of BRD4 PROTAC Based on Alkenyl Oxindole-DCAF11 Pair

Man Zhao, Wenjing Ma, Jinyi Liang, Yubao Xie, Tianzi Wei, Ming Zhang, Jiajie Qin, Lingyin Lao, Ruilin Tian, Haiqiang Wu iD, Jin Cheng, Min Li und 3 weitere

Journal of Medicinal Chemistry · 14.11.2024 · 67 (21) · 19428-19447

DOI: 10.1021/acs.jmedchem.4c01767 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 30.10.2024. Verfasst von Man Zhao und 14 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China. Hauptthemen laut MEDLINE: Transcription Factors, Cell Cycle Proteins, Oxindoles, Drug Design. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 42 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province, Chinese Academy of Medical Sciences, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Proteolytic targeting chimera (PROTAC) represent an advanced strategy for targeting undruggable proteins, and the molecular warheads targeting E3 ligases play a crucial role. Recently, we explored an alkenyl oxindole warhead targeting the E3 ligase DCAF11 and sought to validate its potential. In this study, we synthesized a range of BRD4 PROTACs (8a-8o, 14a-14f, 22a-22m) with modified alkenyl oxindole warheads and developed a high-throughput screening system based on high-content imaging. We identified L134 (22a) as a potent BRD4 degrader, achieving BRD4 degradation (Dmax > 98%, DC50 = 7.36 nM) and demonstrating antitumor activity. Mechanically, BRD4 degradation by L134 was mediated through the ubiquitin-proteasome system in a DCAF11-dependent manner. Therefore, this study provides a rapid screening method for effective PROTACs and highlights the PROTAC L134 based on alkenyl oxindole-DCAF11 pair as a promising candidate for treating BRD4-driven cancers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcription FactorsCell Cycle ProteinsOxindolesDrug DesignProteolysisHumansAntineoplastic AgentsCell Line, TumorUbiquitin-Protein LigasesStructure-Activity RelationshipAnimalsHigh-Throughput Screening AssaysBromodomain Containing Proteins

Substanzen

BRD4 protein, humanTranscription FactorsCell Cycle ProteinsOxindolesAntineoplastic AgentsUbiquitin-Protein LigasesBromodomain Containing Proteins

Autor:innen und Institutionen

  • School of Pharmacy, Shenzhen University Medical School, Shenzhen University, Shenzhen 518060, China.
  • Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China.
  • Guangdong Key Laboratory of Chiral Molecule and Drug Discovery, School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.
  • Key University Laboratory of Metabolism and Health of Guangdong, Department of Medical Neuroscience, School of Medicine, Southern University of Science and Technology, Shenzhen 518055, China.
  • The Affiliated Wuxi Center for Disease Control and Prevention, Wuxi Center for Disease Control and Prevention, Nanjing Medical University, Wuxi 214023, China.

ORCID-Profile: Haiqiang Wu, Liang Hong, Guofeng Li

Förderung

  • Natural Science Foundation of Jiangsu Province
  • Chinese Academy of Medical Sciences
  • National Natural Science Foundation of China
  • Top Talent Support Program for young and middle-aged people of Wuxi Health Committee

Zitieren

APA

Zhao, M., Ma, W., Liang, J., Xie, Y., Wei, T., Zhang, M., Qin, J., Lao, L., Tian, R., Wu, H., Cheng, J., Li, M., Liu, Y., Hong, L., & Li, G. (2024). Design, Synthesis, and Activity Evaluation of BRD4 PROTAC Based on Alkenyl Oxindole-DCAF11 Pair. Journal of Medicinal Chemistry, 67(21), 19428-19447. https://doi.org/10.1021/acs.jmedchem.4c01767

Vancouver

Zhao M, Ma W, Liang J, Xie Y, Wei T, Zhang M, et al. Design, Synthesis, and Activity Evaluation of BRD4 PROTAC Based on Alkenyl Oxindole-DCAF11 Pair. Journal of Medicinal Chemistry. 2024;67(21):19428-19447. doi:10.1021/acs.jmedchem.4c01767

BibTeX
@article{Zhao2024,
  author = {Zhao, Man and Ma, Wenjing and Liang, Jinyi and Xie, Yubao and Wei, Tianzi and Zhang, Ming and Qin, Jiajie and Lao, Lingyin and Tian, Ruilin and Wu, Haiqiang and Cheng, Jin and Li, Min and Liu, Yuyang and Hong, Liang and Li, Guofeng},
  title = {Design, Synthesis, and Activity Evaluation of BRD4 PROTAC Based on Alkenyl Oxindole-DCAF11 Pair},
  journal = {Journal of Medicinal Chemistry},
  year = {2024},
  volume = {67},
  number = {21},
  pages = {19428--19447},
  doi = {10.1021/acs.jmedchem.4c01767}
}
Kostenlos starten →